Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
Prehab_2
1 other identifier
interventional
500
1 country
2
Brief Summary
Elective surgery is the most effective treatment option for colorectal cancer, however it has been recognized to be associated with high morbidity and mortality risks. ERAS (Enhanced Recovery After Surgery) is a preoperative multimodality treatment package, which has been well investigated and proved to be effective in reducing early postoperative morbidity, mortality, length of hospital stay and hospital costs, as well. Still, a good proportion of patients are not suitable for ERAS program, mainly based on lack of compliance and the impaired physical function before surgery. Trimodal Prehabilitation Program is a recently introduced preoperative preparation (training) program, which addresses improvement of physical, mental and nutritional status of the high risk elective surgery patients. This study aims to investigate the benefit of all efforts of a 4-6-week preoperative preparation program (Prehabilitation) being added to an established ERAS protocol. Additionally the effect of trimodal prehabilitation on gut microbiom diversity and its relation to clinical outcome will be analyzed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable colorectal-cancer
Started Sep 2020
Typical duration for not_applicable colorectal-cancer
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 7, 2020
CompletedFirst Submitted
Initial submission to the registry
September 30, 2020
CompletedFirst Posted
Study publicly available on registry
October 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 7, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 7, 2024
CompletedNovember 29, 2024
February 1, 2024
1.9 years
September 30, 2020
November 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
Length of hospital stay
Postoperative length of hospital stay in days.
45 days
Number of days spent on ICU (Intensive care unit).
Number of days observed on ICU right after operation.
45 days
Morbidity (early) classified after Clavien-Dindo.
7-day morbidity will be detailed assessed. Grade 3 or above morbidity rate will be assessed.
7 days (until 8th postoperative day) postoperative
Morbidity (long term) classified after Clavien-Dindo.
30-day morbidity will be detailed assessed. Grade 3 or above morbidity rate will be assessed.
30 days (until 31st postoperative day)
30-day mortality
30-day mortality of each patient will be recorded.
30 days (until 31st postoperative day)
90-day mortality
90-day mortality of each patient will be recorded.
90 days (until 91st postoperative day)
Change in preoperative functional status - 6MWD by operation
6MWD (6-minute walking distance test)
Measured points: 4 weeks before surgery, on day of hospital admission
Change in postoperative functional status - 6MWD by the end of rehabilitation
6MWD (6-minute walking distance test)
Measured points: 4 weeks before surgery, 8 weeks after operation
Change in preoperative functional status - FVC by operation
Measured points: 4 weeks before surgery, on day of hospital admission
Measured points: 4 weeks before surgery, on day of hospital admission
Change in preoperative functional status - FVC by the end of rehabilitation
Measured points: 4 weeks before surgery, 8 weeks after operation
Measured points: 4 weeks before surgery, 8 weeks after operation
Secondary Outcomes (1)
Change of alpha- and beta-diversity of fecal microbata
Measured points: 4 weeks before surgery, on day of hospital admission and 8 weeks after surgery
Study Arms (2)
Trimodal prehabilitation + ERAS
EXPERIMENTALPatients receiving a formal preoperative preparation on: Physical status (walking, respiratory training) Nutrition (nutritional supplements) Mental status (weekly groups led by clinical psychologist on anxiety and depression management). Each patient will be treated in an ERAS program preoperatively.
ERAS + nutritional prehabilitation
ACTIVE COMPARATOREach patient will be treated in an ERAS program preoperatively. No specific preoperative training will be involved apart from nutritional status assessment and nutritional supplements.
Interventions
Prehabilitation will cover a range preoperative education and exercises (weekly) on diet, physical activity (daily walking), respiratory training (forced deep inspiration with spirometer device), as well as anxiolytic group psychotherapy.
Enhanced Recovery Program, including preoperative 4 weeks nutritional supplementation.
Eligibility Criteria
You may qualify if:
- patient with histologically proven primary colorectal adenocarcinoma
- any stage of colorectal cancer
- elective operation
- curative intention
- informed consent signed by patient
You may not qualify if:
- emergency operation
- palliative operation
- non-colorectal, second malignancy
- pregnancy
- patient not giving consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- St. Borbala Hospitallead
- Biological Research Centre, Szegedcollaborator
Study Sites (2)
Department of Surgery, St. Borbala Hospital
Tatabánya, 2800, Hungary
St. Borbala Hospital
Tatabánya, 2800, Hungary
Related Publications (2)
Molenaar CJ, van Rooijen SJ, Fokkenrood HJ, Roumen RM, Janssen L, Slooter GD. Prehabilitation versus no prehabilitation to improve functional capacity, reduce postoperative complications and improve quality of life in colorectal cancer surgery. Cochrane Database Syst Rev. 2023 May 10;5(5):CD013259. doi: 10.1002/14651858.CD013259.pub3.
PMID: 37162250DERIVEDMolenaar CJ, van Rooijen SJ, Fokkenrood HJ, Roumen RM, Janssen L, Slooter GD. Prehabilitation versus no prehabilitation to improve functional capacity, reduce postoperative complications and improve quality of life in colorectal cancer surgery. Cochrane Database Syst Rev. 2022 May 19;5(5):CD013259. doi: 10.1002/14651858.CD013259.pub2.
PMID: 35588252DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Investigators and assessors will be blinded regarding preoperative preparation. Both randomization process and rehabilitation process will be carried out by a trained nurse, physiotherapist and psychotherapist, neither of them will be involved in outcome assessment.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 30, 2020
First Posted
October 20, 2020
Study Start
September 7, 2020
Primary Completion
August 7, 2022
Study Completion
June 7, 2024
Last Updated
November 29, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- 10 years